326030.KS
SK Biopharmaceuticals Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 86,400.00
+0.12%Forward multiples
Based on analyst estimates
- P/E forward
- 42.89x
- P/E 2026E
- 21.47x
- P/E 2027E
- 17.02x
- P/E 2028E
- 12.93x
- P/S forward
- 6.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.47x
- PEG TTM
- —
- Price / book
- 6.47x
- Price / sales
- 7.67x
- Price / cash flow
- 26.27x
Enterprise value
- Enterprise value
- KRW 6.28T
- EV / sales
- 7.29x
- EV / EBITDA
- 26.60x
- EV / EBIT
- 20.70x
- Market cap
- KRW 6.61T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026